Most Gun Owners May Be Excluded From Remington Rifle Class Action Lawsuit

One expert is warning that most owners of Remington 700 rifles will miss being involved in a class action settlement over claims that they have defective triggers. 

According to a report by Law.com, an amicus letter filed last week warns that most of the 7.5 million potential participants of the Remington rifle settlement agreement will miss the opportunity to participate because of a failure to effectively notify them of the potential to join the class action.

The letter is backed by concerns voiced by U.S. District Judge Ortrie Smith in December, who noted that the notice plan only drew 2,327 participants.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The Remington class-action lawsuit settlement was reached in a federal court in Missouri in December, including an agreement that Remington will retrofit an estimated 7.85 million Model 700 and Seven series rifles free of charge.

The Remington Rifles being recalled have been criticized for having faulty trigger designs, which may have been assembled with an excessive bonding agent that could allow the firearms to spontaneously discharge under certain situations.

A number of Remington rifle class action lawsuits were filed in 2013, including one by Ian Pollard, a resident of Missouri whose Remington 700 rifle fired on several occasions even though he didn’t pull the trigger.

The complaints claimed that Remington failed to recognize the possibly safety hazards associated with the certain models as well as negligence, breach of warranty, unfair and deceptive trade practices, and fraudulent concealment.

In June, attorneys on both sides issued a revised notification plan which would use emails, radio ads and Facebook to attempt to reach potential participants, following claims that the notices were insufficient, using ads on the internet, in magazines and social media to reach gun owners.

Customers who have already had their trigger assemblies replaced will be reimbursed by Remington after showing receipt of the service.

Over the last few years, Remington received reports indicating at least 24 deaths and more than 100 serious injuries may have been caused by the faulty trigger systems on Remington rifles that accidentally or spontaneously discharged.

In April, a Remington rifle recall was announced for Model 700 and Model Seven rifles with X-Mark Pro (XMP) triggers. However, the recall only affected Remington 700 and Seven model rifles manufactured between May 1, 2006 and April 9, 2014.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: Image Courtesy of <a href="http://commons.wikimedia.org/wiki/User:Rama" target="_blank" rel="noopener">Rama</a> via Wikimedia Creative Commons



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.